Pelican BioThermal, a global name in temperature-controlled packaging, has opened a network station in Toronto to service its Crēdo on Demand rental programme.
“Canada has become one of the leaders in clinical trials in recent years and Toronto is one of its top logistics hubs,” said Dominic Hyde, vice president of Crēdo on Demand at Pelican BioThermal. “By opening a network station, Canadian clinical trial and life sciences companies now have access to a high performance, flexible rental option for temperature-controlled containers in close proximity to where they develop and innovate.”
Many major pharmaceutical development companies are headquartered in Canada including Novartis, Johnson & Johnson, Gilead, Teva and Apotex. The Canadian pharmaceutical industry is the 10th largest market in the world and by 2021, pharmaceutical sales are expected to reach $25 billion, according to industry analyst GlobalData PLC.
The Toronto network station joins Pelican BioThermal’s growing system of more than 100 network stations and drop points around the world.
